Skip to content

Clinical trials

Phase 2 Acquired Immunodeficiency Syndrome trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Phase 2 Country / region: South Africa Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20082
20095
20112
20142
20153
20191
20201
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting2
Recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ViiV Healthcare4
Centre for the AIDS Programme of Research in South Africa2
GlaxoSmithKline2
Janssen Sciences Ireland UC2
Tibotec Pharmaceuticals, Ireland2
AIDS Malignancy Consortium1
Bayer1
Gates Medical Research Institute1
Janssen R&D Ireland1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome22
HIV Infections5
Infections3
Uterine Cervical Neoplasms2
Cardiovascular Diseases1
Embolism1
Embolism and Thrombosis1
Hepatitis B1
Lung Diseases1
Neuralgia1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.